Company Profile
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitco...
Read ArticleASX 200 drops as gold, iron ore and energy stocks struggle Paladin shares plunge after cutting uran...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleAussie shares slip as RBA holds rates steady MinRes rebounds, Domino’s Don Meij quits Investors ret...
Read ArticleASX 200 hits record highs fuelled by Wall Street rally Tech and iron ore stocks lead gains Tyro...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleANDHealth says the Covid-19 pandemic triggered far-reaching changes to Australia’s health system an...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleFor biotech investors, the news of an approval by the US FDA is a genuinely exciting milestone. The...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleAustralian respiratory eHealth company Adherium (ASX:ADR) has announced that AstraZeneca has...
Read ArticleASX in broad rebound; Cettire, Neuren, and Lendlease lead surge Positive sentiment follows Wall Str...
Read ArticleASX drops over 1pc as tech, retail, banks fall; energy resists Bond yields surge, impacting goldies...
Read ArticleDigital health solutions specialist Adherium (ASX: ADR) is celebrating news that global biopharmaceu...
Read ArticleTo register for today's webinar click here. Adherium (ASX:ADR), a leader in respiratory eHealth, r...
Read Article24 May 2024 - A snapshot of the stocks on the move, featuring Adherium (ASX:ADR), Nanoveu (ASX:NVU)...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleS&P/ASX 200 fell 2.94% in April as all Australian equity indexes fell except Emerging Companies...
Read ArticleAsthma affects hundreds of millions of people globally While inhalers are effective, people are not...
Read ArticleThe ASX slumped by over -1pc, as jitters about delayed rate cuts rattled markets Miner BHP confirme...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleThis week’s Bulls N’ Bears top ASX runner is … Dalaroo Metals. Its share price rose more than 182 pe...
Read ArticleMedical device developer Adherium (ASX: ADR) has been given clearance by the US Food and Drug Admini...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleLocal markets end hopelessly, slightly lower IT sector surges 2.9% Small Caps led by incredible...
Read ArticleLocal markets are lucky to close a smidgen higher IT and Healthcare sectors offset a 2pc loss for...
Read ArticleAdherium (ASX:ADR) says it will be exhibiting and meeting with commercial partners at the Am...
Read ArticleLocal markets end slightly lower Telco Sector jumps 1.5pc Small Caps led by Way2Vat The ASX200...
Read ArticleThe ASX benchmark has ended Wednesday higher after positive inflation data 7 of 11 sectors in the g...
Read ArticleThe ASX benchmark has ended Tuesday higher 8 of 11 sectors in the green Small caps led by Plenti G...
Read ArticleThe ASX benchmark has closed higher on Tuesday Materials sector leads gains, up +1.44% Small caps...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleThe ASX benchmark has closed slightly higher on Monday Energy Sector gains after oil prices rose ov...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleASX200 closes +1.13% higher Property stocks, Industrials and IT Sector gain more than 2% Small caps...
Read ArticleBenchmark ASX closes below 6,800 points All Sectors in red, but for IT Small caps led, in a very b...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleAdherium (ASX:ADR) has commenced production and market release of its new Hailie sensors wit...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, surprisingly close to on time this morning considering...
Read ArticleAustralian digital health company Adherium (ASX:ADR) has announced a new partnership in whic...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX 200 benchmark falls, gains and wanes its way to just 0.03% for the day. Real Estate, resources...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleAfter a steep early drop, the benchmark stabilised to close 1.5% down. InfoTech and Materials fared...
Read ArticleASX benchmark falls 0.86% for the day, dragged down by bad news from China. Telcos, Energy and Inf...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleLocal markets have risen from the dead again, closing at +0.26% for the day. Bowen Coking Coal has...
Read ArticleASX benchmark finishes the flat, after struggling to find traction since mid-morning Health Care r...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleDigital health company Adherium (ASX:ADR) has signed a collaboration agreement with US-based...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best...
Read ArticleThe ASX 200 built a platform for success today. Which failed. It fell flat at close Sectors wise, F...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleThe ASX 200 fell 1.37%, and the bad news kept piling up all day Inflation data knee-capped the mark...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe ASX 200 benchmark waddled its way to a regrettable 0.45% end to the day Materials the only sect...
Read ArticleAfter a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today,...
Read ArticleThe ASX 200 turned Hump Day into Slump Day, dropping 1.1% Goldies shone bright under trying conditi...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe S&P ASX 200 closed up 0.2%, while the S&P XEC fell 0.61% Polymetal Resources soars 64%...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX closes up 0.78%, while XEC rises 1.91% following global markets higher Morningstar warns of pos...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX closes up ~1%, while XEC rises 1.21% following global markets higher Rabobank expects the RBA t...
Read ArticleASX 200 sinks to -2.2% before recovering to close near -1.5% for the day Energy sector tanks -5.0%...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleASX scuttled by bleak rates outlook in the US, down 0.83% for the day RBA boss Philip Lowe had bett...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe ASX slid to close flat today, after realising we were in danger of making some money Materials...
Read ArticleThe ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers fro...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleSuper fund Australian Retirement Trust buys into scandal-plagued Star Entertainment Group State Str...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleThe ASX 200 dropped 0.30% and the ASX XEC declined 0.20% Only 4 out of 11 sectors were higher, with...
Read ArticleThe ASX 200 rose up 0.07%, ASX XEC was up 0.57% Only 6 out of 11 sectors were higher, with Tech le...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleAdherium (ASX:ADR) has announced an award for a pathfinder service development project from...
Read ArticleAudiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Ri...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleASX 200 ends 0.7% higher Small cap index flat NYM, BEZ, CPH best in show Lithium keeps finding...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX 200 halves gains on the run home Small cap index closes about 0.7% higher Tinkler takes more J...
Read ArticleASX 200 closes with -1.8% loss Small cap index down -1.2% Up way more than 100% is Norfolk Minerals...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX 200 limps home with 0.1% gain Small cap index drags itself almost to close flat WR1 cops speedi...
Read ArticleASX closes out the day lower by about 0.74% Online matchmakers Love Group goes on a bodice-busting...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleASX 200 ends 0.3% higher Small caps ahead 0.4% Dr Oliver says go climb the wall of worry, Dolorean...
Read ArticleASX slides early and long on Monday Small cap index crashes -2.3% Besra Gold (ASX:BEZ) just tripled...
Read ArticleAussie markets end Friday on a -0.80% disappointment US signals new cannabis laws, good news for Au...
Read ArticleBenchmark finishes up after fierce struggle for buoyancy Absolutely no one shocked to learn Star’s...
Read ArticleBenchmark spikes, falls, recovers, trips again, stays down. Small caps just fall Delta Drones, Da...
Read ArticleASX 200 down 0.5% Small caps crash about 1.1% OXR up 50% on some quality HR And that’s how y...
Read ArticleBenchmark set to end the day down about 2.0% Geopolitics and overseas rate-raising spree weigh heav...
Read ArticleThe ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40...
Read ArticleRespiratory eHealth company Adherium (ADR) is set to raise $13.5 million through a private share pla...
Read ArticleAdherium (ADR) enters into a trading halt pending a capital raise announcementThe company is plannin...
Read ArticleThe ASX 200 falls 2.6% after Wall St rout Small caps recover manfully to be just 1% lower AQC is...
Read ArticleRespiratory medical devices business Adherium was out with a steeply discounted $13.5 million placem...
Read ArticleThe ASX will open higher on Friday Fed’s Powell warns of more rate hikes ECB makes a historic 75bp...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleLocal markets follow Wall St ‘hopetimism’ lower Small caps smashed, down circa 3% Pot stock CAU del...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleAdherium (ASX: ADR) has announced that it has received US FDA clearance to market applicatio...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleRespiratory eHealth company Adherium (ADR) signs its first UK distribution deal with Helicon Health...
Read ArticleBenchmark and small cap index down hard Life on the indices can be hard, unless your in energy, pos...
Read ArticleRespiratory eHealth company Adherium (ASX:ADR) has announced the appointment of Tara Creaven...
Read ArticleAussie small cap index falls 1.4% The ASX200 down 1.65% Thursday is Arafura Day! Down less than...
Read ArticleXEC down 2.7% XJO down 1.8% Dateline Resources (ASX: DTR) hits the trifecta Markets across Asia...
Read ArticleRespiratory eHealth, remote monitoring and data management solutions company Adherium (ASX:A...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleDigital health company Adherium (ASX:ADR) has appointed Francis White as the vice president...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleRespiratory eHealth company Adherium (ASX:ADR) has submitted to the US FDA for 510(k) cleara...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleThe ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader in...
Read ArticleDespite closing lower today, the ASX finished 2021 over 13% where it begun. This compares to a loss...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleThe ASX finished 0.67% higher, marking the best performance by the Australian bourse since early Oct...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleThe ASX limped into the close on Friday, in a fairly tame finish to a roller-coaster week. Evergrand...
Read ArticleThe ASX 200 health stocks index (XHJ) is down by 0.82% at the time of writing, compared to the broad...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleHighlights ASX 200 ended the trading session on 10 September 2021 in the green zone. Amani Gol...
Read ArticleThe ASX regained some lost ground from yesterday’s bloodbath, but closed this week lower than what i...
Read ArticleThe Adherium Ltd (ASX: ADR) share price soared to dizzying heights today. This comes after the digi...
Read ArticleAfter treading water since the start of September, the ASX 200 took a dive in Thursday trade to fini...
Read ArticleThe ASX Health Care index (XHJ) was down by 0.11% this morning, compared with the broader ASX 200 in...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleRespiratory eHealth company Adherium (ASX:ADR) has announced that it has received US FDA) 51...
Read ArticleThe ASX 200 rose 0.07%, closing at 7,529 points while the ASX Emerging Companies Index climbed 1.21%...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleThe USA is the world’s largest healthcare market and therefore a dream for ASX health stocks to ente...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleRespiratory eHealth company Adherium (ASX:ADR) has submitted to the US FDA seeking clearance...
Read ArticleIf you want to know which ASX stocks fund managers and famous investors are putting their money into...
Read ArticleThe ASX had a solid start to the week, gaining over 1 per cent and hitting a record high. The ASX 20...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the fir...
Read ArticleAs the quarterlies continue to roll in across the afternoon, here are five prominent companies whose...
Read ArticleSummary NTL price of New Talisman Gold Mines hit a two-month high today, trading 33.3% higher at...
Read ArticleIf you want to know which ASX stocks fund managers and famous investors are putting their money into...
Read ArticleLeading healthcare investment firm BioScience Managers argues digital therapeutics will be the next...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralian company Adherium (ASX:ADR), which is focused on respiratory eHealth, remote monit...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleThe ASX finished in the red today dragged down by resources and energy. Materials and Energy stocks...
Read ArticleThe ASX had a positive day today gaining 0.8 per cent and all sectors finished in the green except r...
Read ArticleSource:New Africa ,Shutterstock Summary COVID-19 had a significant impact on the HeraMED’s and...
Read ArticleThe company develops, manufactures and supplies a broad range of connected medical devices for respi...
Read ArticleA quick wrap of the ASX’s key winners and losers on Monday, August 31. Data is taken after the marke...
Read ArticleThe sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have...
Read ArticleAustralian company Adherium (ASX: ADR) has announced the appointment of Geoff Feakes as its...
Read ArticleTelehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both list...
Read ArticleA quick wrap of the ASX’s key winners and losers on Monday, July 13. Data is taken after the market...
Read ArticleCOVID-19 has forced many companies to adjust the way they operate and many companies think it will b...
Read ArticleA quick wrap of the key winners and losers on Thursday, April 30. Data is taken after the market clo...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleThe announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders b...
Read ArticleJohn Athanasiou, Red Leaf Securities BUY RECOMMENDATIONS Adherium (ADR) Chart: Share price over th...
Read ArticleGlobal funding for telehealth companies surged in the March quarter as investors jumped on what will...
Read ArticleNew Zealand-based Adherium (ASX: ADR) is set to form a collaborative alliance with US-based HGE Heal...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleIt’s Tuesday team. Here’s what’s going on in the world. 1. US politician who invested in an ASX...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 136-odd small ca...
Read ArticleThe new-look ServTech is pushing its virtual reality technology into dentistry training, being paid...
Read ArticleAir pollution is a growing problem that in recent days has reached our own backyard. Because of the...
Read ArticleDigital health company Adherium(ASX:ADR) has appointed Dr Peter Stratford as its CEO and Mik...
Read ArticleHeraMED’s (ASX:HMD) foetal ultrasound heart rate monitor has got its long awaited green light to ent...
Read ArticleHere’s our fortnightly wrap of the major small cap health stock winners and losers. For the second f...
Read ArticleAt the close of trading session on 24th October 2019, the benchmark index, i.e. S&P/ ASX 200 clo...
Read ArticleOn Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers wi...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAustralian respiratory medical device company Adherium (ASX:ADR) has announced a new strateg...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAdherium (ASX: ADR) shares have risen 19 per cent this morning following news the asthma monitoring...
Read ArticleOpen an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.